HeraMED Limited (ASX:HMD)
Australia · Delayed Price · Currency is AUD 0.0340
-0.0010 (-2.86%)
Sep 15, 2025, 10:24 AM AEST
HeraMED Revenue
HeraMED had revenue of 139.49K AUD in the half year ending June 30, 2025, a decrease of -53.16%. This brings the company's revenue in the last twelve months to 322.93K, down -34.01% year-over-year. In the year 2024, HeraMED had annual revenue of 364.33K, down -39.90%.
Revenue (ttm)
322.93K
Revenue Growth
-34.01%
P/S Ratio
109.61
Revenue / Employee
n/a
Employees
n/a
Market Cap
35.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 364.33K | -241.90K | -39.90% |
| Dec 31, 2023 | 606.23K | 284.14K | 88.22% |
| Dec 31, 2022 | 322.09K | 202.92K | 170.27% |
| Dec 31, 2021 | 119.18K | 67.95K | 132.67% |
| Dec 31, 2020 | 51.22K | -155.73K | -75.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Pro Medicus | 212.98M |
| Cochlear | 2.34B |
| Sonic Healthcare | 9.65B |
| Ramsay Health Care | 17.79B |
| Ansell | 3.06B |
| Telix Pharmaceuticals | 1.01B |
| Mesoblast | 26.23M |